GD2 Expression in Medulloblastoma and Neuroblastoma for Personalized Immunotherapy: A Matter of Subtype

SIMPLE SUMMARY: Molecular analyses discussed in Molecular Tumor Boards are expected to improve cancer treatment by identifying tumor-specific alterations. Here, we quantified the expression of the gangliosides GD2 and N-glycolyl GM3 in neuroblastoma and medulloblastoma, two aggressive pediatric tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Paret, Claudia, Ustjanzew, Arsenij, Ersali, Sara, Seidmann, Larissa, Jennemann, Richard, Ziegler, Nicole, Malki, Khalifa El, Russo, Alexandra, Wingerter, Arthur, Ortmüller, Franziska, Bornas, Angelina, Wehling, Pia Charlotte, Lepădatu, Adina, Ottenhausen, Malte, Roth, Wilfried, Sommer, Clemens, Fliss, Barbara, Frauenknecht, Katrin B. M., Sandhoff, Roger, Faber, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775636/
https://www.ncbi.nlm.nih.gov/pubmed/36551537
http://dx.doi.org/10.3390/cancers14246051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775636/
https://www.ncbi.nlm.nih.gov/pubmed/36551537
http://dx.doi.org/10.3390/cancers14246051

Ejemplares similares